SVB Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $511K | Sell |
7,319
-4,120
| -36% | -$288K | 0.03% | 294 |
|
2025
Q1 | $841K | Sell |
11,439
-532
| -4% | -$39.1K | 0.03% | 171 |
|
2024
Q4 | $784K | Buy |
+11,971
| New | +$784K | 0.01% | 363 |
|
2024
Q3 | – | Sell |
-13,444
| Closed | -$1.05M | – | 70 |
|
2024
Q2 | $1.05M | Buy |
13,444
+228
| +2% | +$17.8K | 0.03% | 309 |
|
2024
Q1 | $895K | Sell |
13,216
-7,801
| -37% | -$529K | 0.02% | 365 |
|
2023
Q4 | $1.42M | Buy |
21,017
+868
| +4% | +$58.5K | 0.03% | 288 |
|
2023
Q3 | $1.36M | Sell |
20,149
-1,332
| -6% | -$90.2K | 0.03% | 275 |
|
2023
Q2 | $1.54M | Sell |
21,481
-2,454
| -10% | -$176K | 0.03% | 276 |
|
2023
Q1 | $1.66M | Sell |
23,935
-1,011
| -4% | -$70.2K | 0.02% | 299 |
|
2022
Q4 | $1.69M | Buy |
24,946
+615
| +3% | +$41.7K | 0.02% | 296 |
|
2022
Q3 | $1.33M | Buy |
24,331
+4,281
| +21% | +$235K | 0.02% | 321 |
|
2022
Q2 | $1.33M | Buy |
20,050
+2,116
| +12% | +$140K | 0.02% | 276 |
|
2022
Q1 | $1.19M | Sell |
17,934
-14,229
| -44% | -$944K | 0.02% | 302 |
|
2021
Q4 | $1.87M | Buy |
32,163
+25,873
| +411% | +$1.51M | 0.03% | 231 |
|
2021
Q3 | $378K | Buy |
6,290
+103
| +2% | +$6.19K | ﹤0.01% | 692 |
|
2021
Q2 | $370K | Sell |
6,187
-8,943
| -59% | -$535K | ﹤0.01% | 672 |
|
2021
Q1 | $752K | Buy |
15,130
+5,524
| +58% | +$275K | 0.01% | 419 |
|
2020
Q4 | $480K | Buy |
9,606
+511
| +6% | +$25.5K | 0.01% | 487 |
|
2020
Q3 | $498K | Buy |
9,095
+1,268
| +16% | +$69.4K | 0.01% | 403 |
|
2020
Q2 | $414K | Buy |
7,827
+2,254
| +40% | +$119K | 0.01% | 397 |
|
2020
Q1 | $249K | Buy |
5,573
+948
| +20% | +$42.4K | 0.01% | 420 |
|
2019
Q4 | $231K | Buy |
+4,625
| New | +$231K | ﹤0.01% | 544 |
|
2017
Q2 | – | Sell |
-7,275
| Closed | -$227K | – | 481 |
|
2017
Q1 | $227K | Buy |
+7,275
| New | +$227K | 0.01% | 444 |
|
2015
Q4 | – | Sell |
-7,350
| Closed | -$234K | – | 538 |
|
2015
Q3 | $234K | Buy |
+7,350
| New | +$234K | 0.01% | 493 |
|